Reaction
Change Of Bowel Habit reporting signals
As of the last recalculation, Change Of Bowel Habit appears in 2,022 FAERS reports alongside 37 co-occurring drug terms. The strongest observed disproportionality signal is ORLISTAT (PRR 108.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Orlistat | 240 | 108.1 | 109.1 |
| Atropine | 27 | 34.0 | 34.1 |
| Nitrofurantoin | 43 | 27.4 | 27.5 |
| Nitrofurantoin (Monohydrate/Macrocrystals) | 43 | 27.0 | 27.1 |
| Atropine Sulfate | 27 | 26.1 | 26.1 |
| Indapamide | 44 | 25.8 | 25.9 |
| Acetaminophen And Codeine | 27 | 23.1 | 23.2 |
| Aprepitant | 40 | 22.7 | 22.8 |
| Octreotide Acetate | 51 | 17.6 | 17.6 |
| Temazepam | 49 | 13.7 | 13.7 |
| Regorafenib | 14 | 12.5 | 12.5 |
| Magnesium Hydroxide | 12 | 9.2 | 9.2 |
| Botulinum Toxin Type A | 11 | 9.2 | 9.2 |
| Leucovorin Calcium | 16 | 8.7 | 8.7 |
| Extended Phenytoin Sodium | 14 | 8.7 | 8.7 |
| Niraparib | 16 | 7.5 | 7.5 |
| Exenatide | 37 | 7.4 | 7.4 |
| Polyethylene Glycol 3350 | 54 | 5.9 | 6.0 |
| Tafamidis | 6 | 5.3 | 5.3 |
| Icosapent Ethyl | 4 | 4.8 | 4.8 |
| Lumacaftor And Ivacaftor | 4 | 4.8 | 4.8 |
| Lapatinib | 7 | 4.7 | 4.7 |
| Teduglutide | 6 | 4.6 | 4.6 |
| Sorafenib | 9 | 4.5 | 4.5 |
| Atomoxetine Hydrochloride | 10 | 4.3 | 4.3 |
| Bevacizumab | 51 | 4.3 | 4.3 |
| Varenicline Tartrate | 29 | 3.8 | 3.8 |
| Apalutamide | 4 | 3.5 | 3.5 |
| Rifaximin | 7 | 3.4 | 3.4 |
| Bosutinib | 3 | 3.4 | 3.4 |
| Elexacaftor, Tezacaftor, And Ivacaftor | 4 | 3.3 | 3.3 |
| Dornase Alfa | 5 | 2.6 | 2.6 |
| Patiromer | 3 | 2.2 | 2.2 |
| Hydrocodone Bitartrate | 8 | 1.9 | 1.9 |
| Voxelotor | 4 | 1.8 | 1.8 |
| Abaloparatide | 5 | 1.8 | 1.8 |
| Copper | 5 | 1.2 | 1.2 |